# US 6,730,308 B1 · Tazarotene and alpha hydroxy acid treatment for psoriasis and/or photodamage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,308 B1
- Document ID: US6730308B1
- Status: Granted
- Kind: B1
- Application number: 09/264,531
- Filed: 1999-03-08
- Granted: 2004-05-04
- Earliest claimed: 1999-03-08
- Assignees: Allergan, Inc.
- Inventors: John Sefton
- Web page: https://patentgrep.com/patent/US6730308B1

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/4436: containing a heterocyclic ring having sulfur as a ring hetero atom
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a method of treating psoriasis and/or photo damage in humans with tazarotene in a topical composition from 0.01 to 15% by weight tazarotene, and an alpha or beta-hydroxy acid in a topical composition comprising from 1 to 25% by weight alpha or beta-hydroxy acid. Furthermore, the present invention relates to treating or preventing psoriasis and/or photo damage by topically applying to the skin of a human, tazarotene, such as a gel comprising 0.01% to 0.1%, tazarotene by weight, and an alpha hydroxy acid, such as a cream, comprising 5% to 20% alpha hydroxy acid, e.g. glycolic acid, by weight.

## Claims

### Claim 1

A method for treating psoriasis and/or photodamage and/or acne in a human subject by topically applying to the psoriatic or sundamaged skin and/or acne of said subject an effective amount of tazarotene and an effective amount of an alpha hydroxy acid.

### Claim 2 (depends on 1)

The method of claim 1 wherein tazarotene is applied as a 0.1% gel.

### Claim 3 (depends on 2)

The method of claim 2 wherein said alpha hydroxy acid is glycolic acid and is applied as a cream comprising 20% by weight, glycolic acid.

### Claim 4 (depends on 1)

The method of claim 1 wherein tazarotene is administered once daily in the evening and said alpha hydroxy acid is glycolic acid and is administered once daily in the morning or evening or twice daily in the morning and evening.
